Rhinoviruses as critical agents in severe bronchiolitis in infants

Juliana Cristina Santiago Bastos1, Paulo Vitor Marques Simas2, Leonardo Cardia Caserta3

  • 1Universidade Estadual de Campinas (UNICAMP), Instituto de Biologia, Departamento de Genética, Evolução, Microbiologia e Imunologia, Laboratório de Virologia Animal, Campinas, SP, Brazil.

Jornal De Pediatria
|December 23, 2021
PubMed

Insights

Severe bronchiolitis in infants is not always caused by Respiratory Syncytial Virus (RSV). Rhinoviruses were more prevalent in severe cases, highlighting the need for broad viral diagnostic testing in pediatric respiratory infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • Bronchiolitis is a common respiratory infection in infants.
  • Respiratory Syncytial Virus (RSV) is often considered the primary cause of severe bronchiolitis.

Purpose of the Study:

  • To detect RSV and other respiratory viruses in infants with severe bronchiolitis.
  • To investigate the etiological agents of severe bronchiolitis in young children.

Main Methods:

  • An epidemiological analytical study involving 173 hospitalized children under two years old.
  • Nasopharyngeal aspirates were analyzed for viral detection.
  • Statistical analysis included Pearson's chi-squared test with a significance level of 0.05.

Main Results:

  • RSV A and B were detected in 47% and 16% of samples, respectively.
  • Nearly one-third of severe bronchiolitis cases were RSV-negative.
  • Rhinoviruses were identified in approximately 25% of positive samples, being more prevalent than RSV in some severe cases.

Conclusions:

  • Severe bronchiolitis in infants is not exclusively caused by RSV.
  • Rhinoviruses are a significant etiological agent in severe pediatric bronchiolitis.
  • Routine viral diagnosis in emergency settings is recommended for all pediatric respiratory infections.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
377
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
422
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
386
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
232
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
704
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.0K